The recall involves Lot# GMML24026A (NDC# 29300-415-19) with an expiration date of September 2027. Unichem Pharmaceuticals is recalling 1 lot of Cyclobenzaprine Hydrochloride Tablets USP, 10mg due to ...

08/27/2025– East Brunswick, NJ, Unichem Pharmaceuticals (USA), Inc. is voluntarily recalling one (1) lot of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, to the consumer level. The Cyclobenzaprine ...

If you’re looking at treatment options for muscle spasms you may want to learn more about cyclobenzaprine (Amrix, Fexmid). It’s a generic prescription drug used along with physical therapy and rest to ...

Cyclobenzaprine is a generic prescription oral tablet used to treat muscle spasms. It does not come in any brand-name versions. Cyclobenzaprine can cause mild to serious side effects, including ...

Cyclobenzaprine is a generic drug that’s prescribed for muscle spasms. As with other drugs, cyclobenzaprine can cause side effects, such as drowsiness and anxiety. Cyclobenzaprine oral tablets are not ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A sublingual tablet form of the muscle relaxant ...

Unichem Pharmaceuticals has recalled one lot of a muscle relaxer because the pills in the bottle might not be the muscle relaxer on the label. The East Brunswick, New Jersey, company’s FDA-posted ...

Amrix (cyclobenzaprine hydrochloride) is a brand-name drug that’s prescribed to help relieve muscle spasms in adults. Amrix comes as an extended-release oral capsule. It’s typically taken once per day ...

Please provide your email address to receive an email when new articles are posted on . Patients with fibromyalgia receiving cyclobenzaprine demonstrated less pain compared with patients receiving ...

TONMYA is a unique, non-opioid, once-daily bedtime analgesic that significantly reduces fibromyalgia pain and is generally well-tolerated "The availability of TONMYA is a momentous day for Tonix, ...

A novel formulation of the muscle relaxant drug cyclobenzaprine has won FDA approval for treating fibromyalgia, manufacturer Tonix Pharmaceuticals announced on Friday. To be sold as Tonmya, the ...

In August 2025, the US Food and Drug Administration (FDA) approved Tonmya ® (cyclobenzaprine hydrochloride sublingual tablets; Tonix Pharmaceuticals) for the treatment of fibromyalgia in adults. Study ...